Nasdaq:US$19.10 (-0.15) | HKEX:HK$30.70 (+0.35) | AIM:£3.12 (+0.07)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility